Research

July 1, 2019

Benzodiazepine use with opioids intensifies neonatal abstinence syndrome

Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.

By Holly Fletcher
June 26, 2019

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.

By Tom Wilemon
David Morrison, MD, and colleagues are studying whether to implant an artificial intraocular lens or fit a contact lens over a baby’s cornea after cataract surgery.
June 26, 2019

Study explores treatment options for babies with cataracts

Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.

By Bill Snyder
June 20, 2019

ABIM Foundation honors VUMC-authored paper

The ABIM Foundation has awarded the 2019 John A. Benson Jr., MD Professionalism Article Prize to five scholarly articles — one commentary and four research pieces — that explore physician burnout, unprofessional behavior and integrity in research.

By Kathy Whitney
June 18, 2019

Study identifies critical regulator of tumor-specific T cell differentiation

A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

By Tom Wilemon
June 13, 2019

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.

By Tom Wilemon
June 13, 2019

Eng named to GI cancer leadership position at VICC

Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
June 13, 2019

Study seeks to expand treatment options for rare airway disease

Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.
By Kelsey Herbers
June 13, 2019

Treatment approved for patients with acute graft-versus-host disease

The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC's Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.
By Tom Wilemon
June 6, 2019

VUMC joins international effort to speed vaccine development

VUMC has joined an international effort to streamline and accelerate development of vaccines and other treatments against a growing worldwide surge of deadly and debilitating viral infections.
By Bill Snyder
June 6, 2019

Study sheds light on importance of comprehension when obtaining consent

Bioethics study focuses on comprehension of informed consent for research
By Doug Campbell
June 29, 2018

Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.
By Bill Snyder
May 24, 2018

Seven interdisciplinary programs land TIPs awards for 2018

Vanderbilt University’s transformational Trans-Institutional Programs initiative heads into a fourth year with grants awarded to seven interdisciplinary projects that involve more than 60 faculty members.
By VUMC News and Communications
1 … 47 48 49 50 51 … 56